Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Basic Res Cardiol. 2011 Sep 4;106(6):1087–1097. doi: 10.1007/s00395-011-0215-7

Table 3.

Hemodynamic and anatomical measurements (n=7)

Measurements at 4-weeks RV/BW (mg/g) Lung/BW (mg/g) HR (beats/min) MAP (mmHg) PP (mmHg) LVEDP (mmHg)
HF + PVN SN50 0.78±0.08 5.6±0.4 337±12 98±7 31±4 17.72±1.31*
HF + PVN SN50M 1.17±0.10* 10.8±0.6* 340±13 97±7 34±5 23.81±1.80*
HF + PVN vehicle 1.20±0.11* 11.2±0.6* 342±13 95±6 33±5 23.74±1.82*
SHAM + PVN SN50 0.61±0.05 4.7±0.4 332±11 105±8 35±4 6.14±1.59
SHAM + PVN SN50M 0.66±0.05 5.0±0.4 330±13 108±9 34±5 6.53±1.42
SHAM + PVN vehicle 0.69±0.06 5.3±0.5 335±12 107±9 36±5 7.05±1.56

SHAM: sham-operated control; HF: heart failure; BW: body weight; RV: right ventricular; HR: heart rate; MAP: mean arterial pressure; PP: pulse pressure; LVEDP: left ventricular end-diastolic pressure. Values are mean±SEM.

*

P<0.05 versus SHAM groups.

P<0.05 HF+PVN SN50 versus HF+PVN vehicle or HF+PVN SN50M.